Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (14 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.

Scotland · NHS Scotland MSAN

Reboxetine (Edronax®) 4mg tablets

MSAN(2019)20 · Level 2 · issued 22 Nov 2019

Reference: MSAN(2019)20
Issued: 22 Nov 2019
Priority: Level 2
Valid until: w/c 16 December 2019 as stated by the source
Source: Signed NHS Scotland notice (PDF) ↗

What the notice states

The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.

Product	Position	Resupply
1. Reboxetine (Edronax®) 4mg tablets will be out of stock from w/c 2 December until w/c 16	Out of stock	w/c 16
2. Limited supplies of parallel imports and unlicensed imports are available.	Available	—

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

scot:msan:2019:20

Recorded: 13 Aug 2026 22:03 UTC
Capture route: Captured first-hand by ShortageSignal's scheduled check
Read from: NHS Scotland Medicine Supply Alert Notice (PDF)
Captured at: 13 Aug 2026 22:03 UTC
Content hash: e53ae50e0c2763187cffb81782cbb40d300d524d016c576cbc37ffeb5be72444
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document: https://www.publications.scot.nhs.uk/files/msan-2019-20.pdf ↗

From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.